
Sign up to save your podcasts
Or


Award-winning researcher, Dr. Doruk Erkan joins us today with newly published classification criteria for Antiphospholipid Syndrome (APS). Dr. Erkan joins us today with those criteria and why he believes there is sufficient evidence to "Rethink APS".
By American College of Rheumatology4.9
6464 ratings
Award-winning researcher, Dr. Doruk Erkan joins us today with newly published classification criteria for Antiphospholipid Syndrome (APS). Dr. Erkan joins us today with those criteria and why he believes there is sufficient evidence to "Rethink APS".

503 Listeners

296 Listeners

129 Listeners

3,367 Listeners

1,147 Listeners

121 Listeners

119 Listeners

194 Listeners

142 Listeners

519 Listeners

366 Listeners

4 Listeners

183 Listeners

19 Listeners

6 Listeners